🇺🇸 FDA
Patent

US 11446323

Compositions and methods for the treatment of fibrotic diseases

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 11446323 (Compositions and methods for the treatment of fibrotic diseases) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/7105, A61K31/713, A61K9/0019, A61P